The Commission on Cancer (CoC), a quality program of the American College of Surgeons, has granted three-year accreditation to the cancer program at New Hanover Regional Medical Center. Established in 1922 by the American College of Surgeons, the CoC is an association of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care.
To earn voluntary CoC accreditation, New Hanover Regional Medical Center met 34 quality care standards and is required to maintain levels of excellence in the delivery of comprehensive patient-centered care.
NHRMC approaches treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other specialists. This treatment approach results in improved patient care.
The CoC Accreditation Program provides the framework for NHRMC to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease, and end-of-life care.
When patients receive care at NHRMC, they also have access to information on clinical trials and new treatments, genetics counseling, and patient-centered services including social and financial support, nutritional counseling and support, and growing patient navigation and survivorship care support that seek to improve cancer survivors’ journeys and quality of life.
“We are proud to have the only accredited, comprehensive, multi-disciplinary cancer program in southeastern North Carolina. The CoC accreditation is not only an indicator of the excellent quality of cancer care available at NHRMC, but it is recognition of the outstanding team of physicians and staff at Zimmer Cancer Center and their leadership in cancer care in our region,” said Henry Hawthorne, Administrator of Oncology Services.